{
    "2021-06-02": [
        [
            {
                "time": "",
                "original_text": "医药生物行业2020年年报及2021年一季报综述：行业业绩恢复性增长 持续看好创新药等高景气领域",
                "features": {
                    "keywords": [
                        "医药生物",
                        "2020年年报",
                        "2021年一季报",
                        "业绩恢复性增长",
                        "创新药",
                        "高景气领域"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "中泰证券：新冠疫苗接种加速推进，商业化价值有望从二季度开始兑现",
                "features": {
                    "keywords": [
                        "中泰证券",
                        "新冠疫苗",
                        "接种加速",
                        "商业化价值",
                        "二季度"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}